Diana L. Noah

Southern Research Institute — United States

Medicine · Health Sciences

24h-index2.5kcitations43works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Influenza Virus Research Studies(35), Respiratory viral infections research(17), interferon and immune responses(10), Immune Response and Inflammation(9), Animal Disease Management and Epidemiology(7)

Publications43 total

Technology transfer of oil-in-water emulsion adjuvant manufacturing for pandemic influenza vaccine production in Romania: Preclinical evaluation of split virion inactivated H5N1 vaccine with adjuvant
Human Vaccines & Immunotherapeutics·2015· 14 citedOpen Access
Persistence of Antibody to Influenza A/H5N1 Vaccine Virus: Impact of AS03 Adjuvant
Clinical and Vaccine Immunology·2015· 19 citedOpen Access
LSC Abstract – Epithelial sodium channel (ENaC) currents and superoxide and hydroxyl formation in influenza H1N1 infected rat primary alveolar type II cells
2015
Effect of Varying Doses of a Monovalent H7N9 Influenza Vaccine With and Without AS03 and MF59 Adjuvants on Immune Response
JAMA·2015· 138 cited
Phase II trial in adults of concurrent or sequential 2009 pandemic H1N1 and 2009–2010 seasonal trivalent influenza vaccinations
Vaccine·2014· 5 citedOpen Access
Serological Responses to an Avian Influenza A/H7N9 Vaccine Mixed at the Point-of-Use With MF59 Adjuvant
JAMA·2014· 131 cited
Clinical and Immune Responses to Inactivated Influenza A(H1N1)pdm09 Vaccine in Children
The Pediatric Infectious Disease Journal·2014· 11 citedOpen Access
Safety, Reactogenicity, and Immunogenicity of Inactivated Monovalent Influenza A(H5N1) Virus Vaccine Administered With or Without AS03 Adjuvant
Open Forum Infectious Diseases·2014· 31 citedOpen Access
LB-2Avian Influenza A/H7N9 Vaccine Mixed with MF59 Adjuvant at the Point-of-Use. A Randomized Clinical Trial of a Pandemic Threat Response
Open Forum Infectious Diseases·2014Open Access
Point-of-Use Mixing of Influenza H5N1 Vaccine and MF59 Adjuvant for Pandemic Vaccination Preparedness: Antibody Responses and Safety. A Phase 1 Clinical Trial
Open Forum Infectious Diseases·2014· 15 citedOpen Access
Non-replicating adenovirus particle as a rapid-prolonged-broad therapeutic agent as well as a vaccine carrier against viral and bacterial infections
Journal of Vaccines & Vaccination·2013
Adapting global influenza management strategies to address emerging viruses
American Journal of Physiology-Lung Cellular and Molecular Physiology·2013· 26 cited
Flagellin-HA vaccines protect ferrets and mice against H5N1 highly pathogenic avian influenza virus (HPAIV) infections
Vaccine·2012· 46 cited
Host Gene Expression Signatures Discriminate between Ferrets Infected with Genetically Similar H1N1 Strains
PLoS ONE·2012· 12 citedOpen Access
Ion Transport And Reactive Oxygen Species Formation In Influenza H1N1 Infected Rat Primary AT II Cells
2012
Phase 2 assessment of the safety and immunogenicity of two inactivated pandemic monovalent H1N1 vaccines in adults as a component of the U.S. pandemic preparedness plan in 2009
Vaccine·2012· 23 citedOpen Access
Comparison of ribavirin and oseltamivir in reducing mortality and lung injury in mice infected with mouse adapted A/California/04/2009 (H1N1)
Life Sciences·2012· 24 citedOpen Access
Immunogenicity of an Inactivated Monovalent 2009 H1N1 Influenza Vaccine in Pregnant Women
The Journal of Infectious Diseases·2011· 105 citedOpen Access
Alanine substitutions within a linker region of the influenza A virus non-structural protein 1 alter its subcellular localization and attenuate virus replication
Journal of General Virology·2011· 11 citedOpen Access
Discovery of Novel Benzoquinazolinones and Thiazoloimidazoles, Inhibitors of Influenza H5N1 and H1N1 Viruses, from a Cell-Based High-Throughput Screen
SLAS DISCOVERY·2010· 31 citedOpen Access
page 1 of 3Next →

Frequent Co-authors

Heather Hill(14), James W. Noah(10), Kathryn M. Edwards(8), Wendy A. Keitel(8), Shital M. Patel(7), Mark Wolff(7), Robert M. Krug(6), David I. Bernstein(5), Irene Graham(5), Lisa A. Jackson(5), C. Buddy Creech(5), Patricia Winokur(5), Sadis Matalon(5), Sharon E. Frey(4), Mark J. Mulligan(4), Nadine Rouphael(4), Michelle Dickey(4), Srilatha Edupuganti(4), E. Lucile White(4), Colleen B. Jonsson(4)